Skip to content
★ Sign in to follow
AI

ACELYRIN, Inc. Stock: price and insider trades · United States

No insider purchase over the last 90 days. The latest, by Westlake BioPartners Fund II, L.P., was filed 11 May 2023.

Insider Decl.
66
Thresholds
n/a
Buy Volume
€23M
11 ops. · all time
Sell Volume
€307,366
7 ops. · all time

ACELYRIN, Inc.: what insiders have been doing

ACELYRIN, Inc. is a listed company. Filings by its managers are published through SEC (Form 4). No insider at ACELYRIN, Inc. has published a filing in the past twelve months. The most recent one dates from 23 May 2025.

Since 2023, the database holds 11 purchases and 7 sales by insiders of the company.

Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Who traded when

BuySale
Amar Murugan1 sale
Mina Kim1 sale
Shephard Mpofu1 sale

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

as of FY 2024

FY ended December 2024 · cache

Income statement
Net income-221M
Last declaration on 23 May 2025

T+90 is the date 90 days after the filing, the exit horizon used to measure each purchase.

Declarations66 total
  • ●
    Chief Executive OfficerExecutives
    0SEC
    770,833 sharesCommon StockSEC:0001962918-25-000068:1
  • ●
    DirectorExecutives
    0SEC
    9,790,729 sharesCommon StockSEC:0001962918-25-000062:1
  • ●
    Related company / holdingExecutives
    0SEC
    9,334,735 shares0Common Stock, par value $0.00001 per share ("Common Stock")SEC:0000902664-25-002533:0
  • ●
    DirectorExecutives
    0SEC
    14,675 sharesCommon StockSEC:0001962918-25-000056:0
  • ●
    DirectorExecutives
    0SEC
    50,000 sharesCommon StockSEC:0001962918-25-000058:0
  • ◆
    Chief Executive OfficerExecutives
    0SEC
    89,526 sharesCommon StockSEC:0001962918-25-000068:0
  • ●
    Chief Medical OfficerExecutives
    0SEC
    121,789 sharesCommon StockSEC:0001962918-25-000060:0
  • ●
    DirectorExecutives
    0SEC
    2,999 sharesCommon StockSEC:0001962918-25-000052:0
  • ●
    Chief Legal OfficerExecutives
    0SEC
    121,587 sharesCommon StockSEC:0001962918-25-000064:0
  • ●
    DirectorExecutives
    0SEC
    15,000 sharesCommon StockSEC:0001962918-25-000054:0
  • ●
    DirectorExecutives
    0SEC
    60,000 sharesCommon StockSEC:0001962918-25-000062:0
  • ◆
    Chief Executive OfficerExecutives
    23,955 USD23SEC
    11,039 shares@ US$2.1710.2% of flowCommon StockSEC:0001962918-25-000038:1
  • ◆
    Chief Executive OfficerExecutives
    22,260 USD23SEC
    10,258 shares@ US$2.179.4% of flowCommon StockSEC:0001962918-25-000038:2
  • ◆
    Chief Executive OfficerExecutives
    0SEC
    30,851 shares0Common StockSEC:0001962918-25-000038:0
  • ▼
    Chief Executive OfficerExecutives
    49,354 USD40SEC
    17,986 shares@ US$2.74426.8% of flowCommon StockSEC:0001962918-25-000031:0
  • ▼
    Chief Legal OfficerExecutives
    10,737 USD34SEC
    3,913 shares@ US$2.744100.0% of flowCommon StockSEC:0001962918-25-000029:0
  • ▼
    Chief Medical OfficerExecutives
    8,811 USD34SEC
    3,211 shares@ US$2.744100.0% of flowCommon StockSEC:0001962918-25-000026:0
  • ◆
    Chief Medical OfficerExecutives
    0SEC
    125,000 shares0Common StockSEC:0001962918-25-000009:0
  • ◆
    Chief Legal OfficerExecutives
    0SEC
    125,000 shares0Common StockSEC:0001962918-25-000005:0
  • ◆
    Chief Executive OfficerExecutives
    0SEC
    575,000 shares0Common StockSEC:0001962918-25-000007:0
  • ▼
    DirectorExecutives
    7 USD11SEC
    1 shares@ US$6.860.0% of flowCommon StockSEC:0001962918-24-000099:0
  • ◆
    Chief Operating OfficerExecutives
    46,032 USD19SEC
    10,298 shares@ US$4.47100.0% of flowCommon StockSEC:0001962918-24-000063:0
  • ◆
    CLO & Head of PeopleExecutives
    4,117 USD19SEC
    921 shares@ US$4.47100.0% of flowCommon StockSEC:0001962918-24-000060:0
  • ◆
    Chief Executive OfficerExecutives
    45,728 USD24SEC
    10,230 shares@ US$4.4724.8% of flowCommon StockSEC:0001962918-24-000061:0
  • ▼
    Chief Executive OfficerExecutives
    66,025 USD25SEC
    9,961 shares@ US$6.628325.2% of flowCommon StockSEC:0001962918-24-000036:0

25 of 66 declarations

About ACELYRIN, Inc.

ACELYRIN, Inc. is a company listed on the XNAS market, focused on developing innovative treatments for serious diseases.

Written on 25 June 2026 from the filings and market data available that day. Live figures are in the blocks above.

The weekly insider digest, free

One email on Fridays: the insider clusters and single-name signals worth reading. Unsubscribe in one click.